Psoriasis-induced by Injected anti-TNF drugs (Paradoxical adverse, reactions): Oral non-TNF targeted therapies ?
The development of psoriasis has been observed in anti-TNF therapies for the treatment of Rheumatoid Arthritis, Ankylosing Spondylitis and Behcet’s disease. Its incidence is estimated to occur in around 5% of cases and is more frequent in females than males. It occurs 5 days to several months after the initiation of treatment in patients in…